Moxifloxacine Teva

Moxifloxacin, the active ingredient in Moxifloxacine Teva, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections, including respiratory and skin infections, in adult patients as prescribed by a healthcare professional.

GNH USA supplies Moxifloxacine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacine Teva is a fluoroquinolone antibiotic used to treat bacterial infections affecting the respiratory tract and skin.

- Community‑acquired pneumonia: eradicates the causative bacteria and improves lung function. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting organisms. - Acute bacterial exacerbation of chronic bronchitis: controls bacterial overgrowth during flare‑ups. - Skin and skin‑structure infections: clears infection in dermal and subdermal tissues.

Moxifloxacine Teva may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort in the stomach area. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function in tendons. - QT interval prolongation: potential cardiac arrhythmia. - Severe allergic reactions: anaphylaxis, swelling, or hives. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Hepatic toxicity: elevated liver enzymes or jaundice. - Peripheral neuropathy: tingling or numbness in extremities.

Before prescribing Moxifloxacine Teva, clinicians should consider several safety measures.

- Assess renal function: adjust use if kidney impairment is present. - Monitor for tendon pain: discontinue if signs of tendonitis appear. - Avoid concomitant QT‑prolonging drugs: reduce risk of cardiac arrhythmias. - Use with caution in elderly patients: higher susceptibility to adverse effects. - Review allergy history: ensure no known hypersensitivity to fluoroquinolones. - Store at below 25°C: keep in the original pack, protect from moisture.

Moxifloxacine Teva can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Other fluoroquinolones: additive toxicity. - QT‑prolonging agents (e.g., macrolides, antiarrhythmics): increased risk of arrhythmia. - Antacids containing magnesium or aluminum: reduced absorption of moxifloxacin. - Warfarin: potential increase in INR and bleeding risk. - Systemic corticosteroids: heightened risk of tendon rupture.

Moderate Interactions (Monitor Closely): - NSAIDs: possible central nervous system effects. - Oral hypoglycemic agents: enhanced hypoglycemia. - Oral contraceptives: reduced efficacy, consider backup method. - Theophylline: increased plasma concentrations. - Cyclosporine: elevated levels may occur.